MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/jmv.28700

Медицинская библиотека · Journal of medical virology · 2023

Performance assessment and validation of a plaque reduction neutralization test (PRNT) in support to yellow fever diagnostic and vaccine clinical trials.

Dia Moussa, Bob Ndeye Sakha, Talla Cheikh, Dupressoir Anne, Escadafal Camille, Thiam Mareme Seye, Diallo Amadou, Ndiaye Oumar, Heraud Jean Michel, Faye Oumar, Sall Amadou Alpha, Faye Ousmane, Fall Gamou

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

Yellow fever (YF) virus is a mosquito-borne virus belonging to the Flaviviridae family that circulates in tropical and subtropical areas of Africa and South America. Despite the availability of an effective vaccine, YF remains a threat to travelers, residents of endemic areas, and unvaccinated populations. YF vaccination and natural infection both induce the production of neutralizing antibodies. Serological diagnostic methods detecting YF virus-specific antibodies demonstrate high levels of cross-reactivities with other flaviviruses. To date, the plaque reduction neutralization test (PRNT) is the most specific serological test for the differentiation of flavivirus infections and is considered the reference method for detecting YF neutralizing antibodies and assessing the protective immune response following vaccination. In this study, we developed and validated a YF PRNT. We optimized different parameters including cell concentration and virus-serum neutralization time period and then assessed the intra- and inter-assay precisions, dilutability, specificity, and lower limit of quantification (LLOQ) using international standard YF serum, sera from vaccinees and human specimens collected through YF surveillance. The YF PRNT has shown good robustness and 100% of intra-assay precision, 95.6% of inter-assay precision, 100% of specificity, 100% of LLOQ, and 95.3% of dilutability. The test is, therefore, suitable for use in the YF diagnostic as well as evaluation of the YF vaccine neutralizing antibody response and risk assessment studies.

Для цитирования: Dia Moussa, Bob Ndeye Sakha, Talla Cheikh, Dupressoir Anne, Escadafal Camille, Thiam Mareme Seye, Diallo Amadou, Ndiaye Oumar, Heraud Jean Michel, Faye Oumar, Sall Amadou Alpha, Faye Ousmane, Fall Gamou. Performance assessment and validation of a plaque reduction neutralization test (PRNT) in support to yellow fever diagnostic and vaccine clinical trials.. Journal of medical virology. 2023. DOI: 10.1002/jmv.28700.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.